oxidopamine has been researched along with Sleep Wake Disorders in 3 studies
Oxidopamine: A neurotransmitter analogue that depletes noradrenergic stores in nerve endings and induces a reduction of dopamine levels in the brain. Its mechanism of action is related to the production of cytolytic free-radicals.
oxidopamine : A benzenetriol that is phenethylamine in which the hydrogens at positions 2, 4, and 5 on the phenyl ring are replaced by hydroxy groups. It occurs naturally in human urine, but is also produced as a metabolite of the drug DOPA (used for the treatment of Parkinson's disease).
Sleep Wake Disorders: Abnormal sleep-wake schedule or pattern associated with the CIRCADIAN RHYTHM which affect the length, timing, and/or rigidity of the sleep-wake cycle relative to the day-night cycle.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Suzuki, M | 1 |
| Nakayama, M | 1 |
| Ando, KB | 1 |
| Arima, S | 1 |
| Nakamura, Y | 1 |
| Yokota, M | 1 |
| Murakami, S | 1 |
| Esteves, AM | 1 |
| Lopes, C | 1 |
| Frank, MK | 1 |
| Arida, RM | 1 |
| Frussa-Filho, R | 1 |
| Tufik, S | 1 |
| de Mello, MT | 1 |
| Chouvet, G | 1 |
| Urbain, N | 1 |
| Vautrelle, N | 1 |
| Dahan, L | 1 |
| Astier, B | 1 |
| Renaud, B | 1 |
3 other studies available for oxidopamine and Sleep Wake Disorders
| Article | Year |
|---|---|
Sleep Disturbance and Hyperactivity Detected by Actigraphy in Rats with Allergic Rhinitis or Attention-Deficit Hyperactivity Disorder.
Topics: Actigraphy; Animals; Attention Deficit Disorder with Hyperactivity; Behavior, Animal; Eosinophilia; | 2018 |
Can physical exercise have a protective effect in an animal model of sleep-related movement disorder?
Topics: Animals; Brain; Disease Models, Animal; Electrocorticography; Electromyography; Exercise Therapy; Ex | 2016 |
[Wakefulness and central basal nuclei: experimental observations and possible implications in Parkinson's disease].
Topics: Animals; Humans; Iontophoresis; Neurons; Neurotransmitter Agents; Oxidopamine; Parkinson Disease; Pa | 2003 |